XERS
NASDAQ · Pharmaceuticals
Xeris Biopharma Holdings Inc
$15.20
+2.12 (+16.21%)
Open$13.79
Previous Close$13.08
Day High$15.21
Day Low$13.53
52W High$13.74
52W Low$5.25
Volume—
Avg Volume3.19M
Market Cap2.68B
P/E Ratio—
EPS$-0.11
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+206.9% upside
Current
$15.20
$15.20
Target
$46.65
$46.65
$35.62
$46.65 avg
$60.75
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 446.02M | 322.38M | 186.74M |
| Net Income | 844.8K | 549.5K | 58.69M |
| Profit Margin | 0.2% | 0.2% | 31.4% |
| EBITDA | 54.62M | 37.51M | 67.69M |
| Free Cash Flow | — | — | 40.84M |
| Rev Growth | +38.4% | +38.4% | +1.9% |
| Debt/Equity | 16.10 | 16.10 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |